Search clinical trials for: SU011248, Sutent

Total 2630 results

M.D. Anderson Cancer Center
Pfizer

Terminated

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Renal Cell Carcinoma | Von Hippel-Lindau Syndrome | Hemangioblastoma

United States
Medstar Health Research Institute
Pfizer

Completed

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer (IIT Sutent)

Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Follicular Thyroid Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Terminated

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Liver Cancer

United States
Yonsei University

Unknown

CONNECT DES Registrty

Myocardial Infarction | Coronary Artery Disease | Ischemic Heart Disease | Stent Stenosis | Stent Thrombosis

Korea, Republic of
Seoul National University Hospital
Medtronic

Unknown

Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent

Coronary Artery Disease

Korea, Republic of
First People's Hospital of Hangzhou

Completed

A Comparison Between Lumen-apposing Metal Stent and Double-pigtail Plastic Stents for Treatment of Walled-off Necrosis

Walled-off Necrosis

China
Columbia University

Terminated

Sunitinib in Certain Subtypes of Soft Tissue Sarcomas

Sarcoma, Soft Tissue

United States
Pfizer

Completed

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

United States
Northern California Melanoma Center
Pfizer; Schering-Plough

Terminated

Temodar and Sutent as Therapy for Melanoma

Metastatic Malignant Melanoma

United States
Pfizer

Completed

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Breast Neoplasms

United States, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Spain, Turkey, Ukraine, United Kingdom
University Health Network, Toronto

Completed

A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Adenoid Cystic Carcinoma | Salivary Gland Cancer

Canada
M.D. Anderson Cancer Center
Pfizer

Active, not recruiting

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma

United States
Micell Technologies
Yale Cardiovascular Research Group; North American Science Associates Inc.; Baim...

Not yet recruiting

Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. (CRYSTAL)

Coronary Artery Disease
Chinese University of Hong Kong
National University Hospital, Singapore; Singapore General Hospital; Changi General... and other collaborators

Completed

Partially Covered Versus Uncovered Pyloro-duodenal Stents for Unresectable Malignant Gastric Outlet Obstruction. A Double Blinded Randomised Controlled Trial.

Unresectable Malignant Gastric Outlet Obstruction

China
Sunnybrook Health Sciences Centre
Pfizer

Completed

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Clear Cell, Metastatic Renal Cell Carcinoma

Canada
National Cancer Institute (NCI)

Completed

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7

United States
University Hospital, Montpellier
University Hospital, Angers; University Hospital, Rouen; University Hospital,... and other collaborators

Terminated

Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled Study

Colorectal Obstruction | Left Colonic Adenocarcinoma
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma

Canada
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent... and other conditions

United States
Universitätsklinikum Hamburg-Eppendorf

Completed

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Acute Myeloid Leukemia

Germany
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Recurrent Uterine Sarcoma | Uterine Leiomyosarcoma

United States
Cairo University
Theodor Bilharz Research Institute; National Hepatology & Tropical Medicine...

Unknown

Kaffes Stent in the Management of Post-surgical Biliary Strictures

Cholangitis | Biliary Stricture | Bile Duct Injury | Bile Duct Stricture | Benign Biliary Stricture

Egypt
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Active, not recruiting

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage IIIC Intraocular Melanoma | Stage I Intraocular Melanoma | Stage IIA Intraocular Melanoma | Stage IIB Intraocular... and other conditions

United States
Cook Research Incorporated

Active, not recruiting

Zenith® p-Branch® Endovascular Graft Pivotal Study

Aortic Aneurysm Abdominal

United States
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes

Canada, United States
University of Wisconsin, Madison
Pfizer; Genentech, Inc.

Completed

Erlotinib and Sunitinib in NSCLC

Non Small Cell Lung Cancer

United States
M.D. Anderson Cancer Center
Pfizer

Completed

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Kidney Cancer | Genitourinary Cancer

United States
University of Miami

Recruiting

ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST

Gastrointestinal Stromal Tumors

United States
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery

Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Cancer | Stage IVB Cervical Cancer | Cervical Adenosquamous Cell Carcinoma

Canada
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer and other conditions

Canada
University Hospital of Ferrara

Recruiting

Analysis of Chemical Pattern Exhaled by Different Neoplasms Through Chemoresistive Nanostructured Sensors

Tumor, Solid

Italy
University of Washington
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Recurrent Thyroid Cancer | Thyroid Gland Medullary Carcinoma | Stage IVA Follicular Thyroid Cancer | Stage IVA Papillary Thyroid Cancer | Stage IVB Follicular Thyroid Cancer | Stage IVB Papillary Thyroid Cancer | Stage IVC Follicular Thyroid Cancer | Stage IVC Papillary Thyroid Cancer

United States
Pfizer

Completed

Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Adult Diffuse Large Cell Lymphoma

Canada
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
Pfizer

Terminated

Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

Colorectal Neoplasms

United States, Denmark, Germany, Japan
Deutsches Herzzentrum Muenchen

Completed

Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography (TEST-6-OCT)

Coronary Heart Disease

Germany
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Adult Anaplastic Astrocytoma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pineal Gland Astrocytoma

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Completed

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Cancer | Head and Neck Cancer | Thoracic Neoplasms | Nervous System Neoplasms | Pelvic Cancer

United States
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma

Classic Kaposi Sarcoma | AIDS-related Kaposi Sarcoma
M.D. Anderson Cancer Center
Novartis

Terminated

Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma

Kidney Cancer

United States
Pfizer

Completed

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies

Neoplasm, Malignant

Japan
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

Fatigue | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
Bassam Abdulkarim
Pfizer; Canadian Cancer Society (CCS)

Unknown

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

Glioblastoma Multiforme

Canada
Pfizer

Completed

SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

United States, Canada, Spain, Australia, Germany, Italy, Russian Federation, Brazil, France, United Kingdom, Poland
Ajou University School of Medicine

Completed

Covered Self-expandable Metallic Stents Insertion Using Clips and Suture Materials for Preventing Migration

Gastroduodenal Anastomosis

Korea, Republic of
Zagazig University

Recruiting

Multihole Fully Covered Metallic Stents in the Management of Malignant Biliary Obstruction

Malignant Biliary Obstruction

Egypt
Pfizer

Completed

Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors

Neoplasms

United States
Glaukos Corporation

Completed

Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication

Open Angle Glaucoma

Armenia

Search clinical trials for: SU011248, Sutent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations